The effects of recombinant human growth hormone therapy on thyroid function in pediatric patients with growth hormone deficiency

BACKGROUND: Recombinant human growth hormone (rhGH) was approved for the therapy of pediatric patients with growth hormone deficiency (GHD) by the Food and Drug Administration (FDA) of the United States in 1985. This study aims to evaluate the effects of rhGH therapy on thyroid function in pediatric...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transl Pediatr
Hlavní autoři: Yao, Qian, Zheng, Dong, Liang, Yan, Hou, Ling, Ying, Yan-Qin, Luo, Xiao-Ping, Wu, Wei
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2021
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8107847/
https://ncbi.nlm.nih.gov/pubmed/34012834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tp-20-401
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky